HRPK20010442B1 - Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites - Google Patents
Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasitesInfo
- Publication number
- HRPK20010442B1 HRPK20010442B1 HR20010442A HRP20010442A HRPK20010442B1 HR PK20010442 B1 HRPK20010442 B1 HR PK20010442B1 HR 20010442 A HR20010442 A HR 20010442A HR P20010442 A HRP20010442 A HR P20010442A HR PK20010442 B1 HRPK20010442 B1 HR PK20010442B1
- Authority
- HR
- Croatia
- Prior art keywords
- ectoparasites
- medicament
- inhibitors
- utilization
- caused
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19858253A DE19858253A1 (de) | 1998-12-17 | 1998-12-17 | Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden |
PCT/EP1999/009547 WO2000035429A1 (de) | 1998-12-17 | 1999-12-07 | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20010442A2 HRP20010442A2 (en) | 2002-06-30 |
HRPK20010442B1 true HRPK20010442B1 (en) | 2003-10-31 |
Family
ID=7891421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20010442A HRPK20010442B1 (en) | 1998-12-17 | 2001-06-14 | Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites |
Country Status (24)
Country | Link |
---|---|
US (2) | US6335363B1 (xx) |
EP (1) | EP1140042B1 (xx) |
JP (1) | JP2002532412A (xx) |
KR (1) | KR20010089574A (xx) |
CN (1) | CN1170528C (xx) |
AR (1) | AR021690A1 (xx) |
AT (1) | ATE390130T1 (xx) |
AU (1) | AU1559500A (xx) |
BR (1) | BR9916190A (xx) |
CA (1) | CA2355300A1 (xx) |
CZ (1) | CZ20012125A3 (xx) |
DE (2) | DE19858253A1 (xx) |
HK (1) | HK1041647B (xx) |
HR (1) | HRPK20010442B1 (xx) |
HU (1) | HUP0200152A3 (xx) |
IL (1) | IL143717A0 (xx) |
NO (1) | NO20012976L (xx) |
NZ (1) | NZ512408A (xx) |
PL (1) | PL349511A1 (xx) |
RU (1) | RU2238090C2 (xx) |
SK (1) | SK8562001A3 (xx) |
TR (1) | TR200101750T2 (xx) |
WO (1) | WO2000035429A1 (xx) |
ZA (1) | ZA200103620B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1718677E (pt) * | 2003-12-19 | 2012-07-18 | Genentech Inc | Fragmentos de anticorpo monovalentes úteis como agentes terapêuticos |
MX2007001470A (es) * | 2004-08-05 | 2007-03-26 | Genentech Inc | Antagonistas anti-cmet humanizados. |
SG185966A1 (en) | 2007-06-07 | 2012-12-28 | Divergence Inc | Control of ectoparasites |
US20100310726A1 (en) | 2009-06-05 | 2010-12-09 | Kraft Foods Global Brands Llc | Novel Preparation of an Enteric Release System |
US9968564B2 (en) | 2009-06-05 | 2018-05-15 | Intercontinental Great Brands Llc | Delivery of functional compounds |
US8859003B2 (en) * | 2009-06-05 | 2014-10-14 | Intercontinental Great Brands Llc | Preparation of an enteric release system |
US20100307542A1 (en) * | 2009-06-05 | 2010-12-09 | Kraft Foods Global Brands Llc | Method of Reducing Surface Oil on Encapsulated Material |
MX2013014687A (es) | 2011-06-30 | 2014-02-17 | Genentech Inc | Formulaciones de anticuerpo anti-c-met. |
US8859005B2 (en) | 2012-12-03 | 2014-10-14 | Intercontinental Great Brands Llc | Enteric delivery of functional ingredients suitable for hot comestible applications |
EP3122900A1 (en) | 2014-03-24 | 2017-02-01 | F. Hoffmann-La Roche AG | Cancer treatment with c-met antagonists and correlation of the latter with hgf expression |
EP2957557A1 (en) * | 2014-06-17 | 2015-12-23 | Novartis Tiergesundheit AG | New compounds |
WO2017136727A2 (en) | 2016-02-05 | 2017-08-10 | Denali Therapeutics Inc. | Compounds, compositions and methods |
ES2912295T3 (es) | 2016-12-09 | 2022-05-25 | Denali Therapeutics Inc | Compuestos útiles como inhibidores de RIPK1 |
PE20200608A1 (es) * | 2017-06-30 | 2020-03-10 | Bayer Animal Health Gmbh | Nuevos derivados de azaquinolina |
TW202334164A (zh) | 2022-01-12 | 2023-09-01 | 美商戴納立製藥公司 | (S)-5-苄基-N-(5-甲基-4-側氧基-2,3,4,5-四氫吡啶並[3,2-b][1,4]氧氮呯-3-基)-4H-1,2,4-***-3-甲醯胺的晶型 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1044116C (zh) * | 1993-11-29 | 1999-07-14 | 默里尔药物公司 | 用作il-1作用抑制剂的苯磺酰亚胺衍生物及其用途 |
US5559026A (en) * | 1994-10-31 | 1996-09-24 | American Cyanamid Company | Genes encoding a novel family of potassium channels |
DE19504379A1 (de) * | 1995-02-10 | 1996-08-14 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate sowie sie enthaltende pharmazeutische Präparate |
SK283837B6 (sk) | 1996-05-15 | 2004-03-02 | Hoechst Aktiengesellschaft | Chrómany, spôsob ich prípravy, liečivá, ktoré ich obsahujú, a ich použitie |
DE19706675A1 (de) | 1997-02-20 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19707656A1 (de) | 1997-02-26 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte anellierte 7-Ring-Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
DE19742508A1 (de) | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
DE19742509A1 (de) | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
DE19748469A1 (de) * | 1997-11-03 | 1999-05-06 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
1998
- 1998-12-17 DE DE19858253A patent/DE19858253A1/de not_active Withdrawn
-
1999
- 1999-12-07 TR TR2001/01750T patent/TR200101750T2/xx unknown
- 1999-12-07 RU RU2001119996/15A patent/RU2238090C2/ru not_active IP Right Cessation
- 1999-12-07 CZ CZ20012125A patent/CZ20012125A3/cs unknown
- 1999-12-07 DE DE59914712T patent/DE59914712D1/de not_active Expired - Lifetime
- 1999-12-07 WO PCT/EP1999/009547 patent/WO2000035429A1/de active IP Right Grant
- 1999-12-07 IL IL14371799A patent/IL143717A0/xx not_active IP Right Cessation
- 1999-12-07 EP EP99958170A patent/EP1140042B1/de not_active Expired - Lifetime
- 1999-12-07 HU HU0200152A patent/HUP0200152A3/hu unknown
- 1999-12-07 NZ NZ512408A patent/NZ512408A/en unknown
- 1999-12-07 AT AT99958170T patent/ATE390130T1/de not_active IP Right Cessation
- 1999-12-07 JP JP2000587750A patent/JP2002532412A/ja not_active Ceased
- 1999-12-07 CA CA002355300A patent/CA2355300A1/en not_active Abandoned
- 1999-12-07 BR BR9916190-7A patent/BR9916190A/pt not_active Application Discontinuation
- 1999-12-07 AU AU15595/00A patent/AU1559500A/en not_active Abandoned
- 1999-12-07 CN CNB998145823A patent/CN1170528C/zh not_active Expired - Fee Related
- 1999-12-07 KR KR1020017007420A patent/KR20010089574A/ko not_active Application Discontinuation
- 1999-12-07 SK SK856-2001A patent/SK8562001A3/sk unknown
- 1999-12-07 PL PL99349511A patent/PL349511A1/xx not_active Application Discontinuation
- 1999-12-15 AR ARP990106411A patent/AR021690A1/es unknown
- 1999-12-16 US US09/461,806 patent/US6335363B1/en not_active Expired - Lifetime
-
2001
- 2001-05-04 ZA ZA200103620A patent/ZA200103620B/en unknown
- 2001-06-14 HR HR20010442A patent/HRPK20010442B1/xx not_active IP Right Cessation
- 2001-06-15 NO NO20012976A patent/NO20012976L/no not_active Application Discontinuation
- 2001-11-16 US US09/987,809 patent/US20020055537A1/en not_active Abandoned
-
2002
- 2002-05-04 HK HK02103407.9A patent/HK1041647B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010089574A (ko) | 2001-10-06 |
HK1041647A1 (en) | 2002-07-19 |
CA2355300A1 (en) | 2000-06-22 |
IL143717A0 (en) | 2002-04-21 |
WO2000035429A1 (de) | 2000-06-22 |
HUP0200152A3 (en) | 2003-01-28 |
SK8562001A3 (en) | 2001-12-03 |
EP1140042B1 (de) | 2008-03-26 |
EP1140042A1 (de) | 2001-10-10 |
JP2002532412A (ja) | 2002-10-02 |
HRP20010442A2 (en) | 2002-06-30 |
NO20012976D0 (no) | 2001-06-15 |
CN1330540A (zh) | 2002-01-09 |
NZ512408A (en) | 2003-10-31 |
NO20012976L (no) | 2001-08-06 |
ZA200103620B (en) | 2002-06-04 |
HUP0200152A2 (hu) | 2002-05-29 |
US6335363B1 (en) | 2002-01-01 |
DE19858253A1 (de) | 2000-06-21 |
AR021690A1 (es) | 2002-07-31 |
TR200101750T2 (tr) | 2002-01-21 |
BR9916190A (pt) | 2001-09-11 |
CZ20012125A3 (cs) | 2001-09-12 |
RU2238090C2 (ru) | 2004-10-20 |
DE59914712D1 (de) | 2008-05-08 |
HK1041647B (zh) | 2005-04-01 |
AU1559500A (en) | 2000-07-03 |
PL349511A1 (en) | 2002-07-29 |
CN1170528C (zh) | 2004-10-13 |
US20020055537A1 (en) | 2002-05-09 |
ATE390130T1 (de) | 2008-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL349511A1 (en) | Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites | |
ID25824A (id) | Formulasi terapeutik untuk memberikan tolterodin dengan pelepasan yang terkendali | |
DK2052714T3 (da) | Topisk gel-fremføringssystem til behandling af hudlidelser | |
DK1268481T3 (da) | Inaseinkibitorer som terapeutiske midler | |
BR9707425A (pt) | Composto processo terapêutico para inibir o crescimento de células cancerosas e processo para utilizar o composto | |
GB9803084D0 (en) | Improvements relating to medical injection devices | |
GB9808408D0 (en) | Improvements relating to injection devices | |
EE04390B1 (et) | Paikne preparaat dermatoloogiliste seisundite raviks | |
GB0401948D0 (en) | Topical composition for treating pain | |
EP1438020A4 (en) | TOPICAL COMPOSITIONS AND METHOD FOR TREATING PAIN | |
DK0925022T3 (da) | Forbedringer med relation til hudprikkenåle | |
ATE436065T1 (de) | Interaktives wettsystem zum wetten nach kriterien | |
AU7138601A (en) | Methods of treating neutrophil-related diseases with topical anesthetics | |
IS6575A (is) | Hýdroxýfenýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka | |
ID28441A (id) | Terapi untuk memperbaiki kesadaran | |
HK1039555A1 (en) | Device for targeted topical treatment of disease | |
ATE232378T1 (de) | Reinigungspflaster zur verbesserung des hautzustandes | |
PL339836A1 (en) | Phtalazine compounds and therapeutic agents suitable to treat erection disorders | |
ZA978400B (en) | Use of inhibitors of the activity of retinoic acid to promote healing. | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
IS6563A (is) | Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka | |
IS6574A (is) | Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka | |
IL138601A0 (en) | Pyrrolidines as inhibitors of neuraminidases | |
ITMI980333U1 (it) | Struttura perfezionata di suola adatta alla traspirazione | |
IL141056A0 (en) | Protease inhibitors for use in the treatment of psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AKOB | Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent) | ||
PKB1 | Consensual patent granted | ||
PNAN | Change of the applicant name, address/residence |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE |
|
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20061117 Year of fee payment: 8 |
|
PBKO | Lapse due to non-payment of renewal fee for consensual patent |
Effective date: 20071208 |